No other factors showed a significant correlation with seroprotection, except for the CD4+ count and the viral load values at the time of the last dose of the primary vaccination series for mumps and the CDC3 stadium in 2023 for tetanus (Table 4). This evidence concerns the gene CD4 and mumps infectious disease.